Appili Therapeutics Inc. (TSX: APLI)
0.0350
0.00 (0.00%)
Jul 18, 2024, 2:59 PM EDT
Appili Therapeutics Employees
As of March 31, 2023, Appili Therapeutics had 9 total employees, including 8 full-time and 1 part-time employees. The number of employees increased by 1 or 12.50% compared to the previous year.
Employees
9
Change (1Y)
1
Growth (1Y)
12.50%
Revenue / Employee
n/a
Profits / Employee
n/a
Market Cap
4.24M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Mar 31, 2023 | 9 | 1 | 12.50% |
Mar 31, 2022 | 8 | -8 | -50.00% |
Mar 31, 2021 | 16 | 4 | 33.33% |
Mar 31, 2019 | 12 | -3 | -20.00% |
Mar 31, 2018 | 15 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Bausch + Lomb Corporation | 13,300 |
Curaleaf Holdings, Inc. | 5,650 |
Bausch Health Companies Inc. | 20,270 |
Tilray Brands, Inc. | 1,600 |
WELL Health Technologies Corp. | 1,507 |
Sienna Senior Living Inc. | 12,000 |
Canopy Growth Corporation | 1,029 |
Extendicare Inc. | 23,000 |
Appili Therapeutics News
- 3 days ago - Appili Therapeutics Announces Second Amendment to Arrangement Agreement - GlobeNewsWire
- 20 days ago - Appili Therapeutics Announces Amendment to Arrangement Agreement and Increase to Bridge Loan - GlobeNewsWire
- 26 days ago - Appili Therapeutics Reports Fiscal Year 2024 Financial and Operational Results - GlobeNewsWire
- 3 months ago - Appili Therapeutics Announces Additional Bridge Loan from Bloom Burton & Co. - GlobeNewsWire
- 3 months ago - Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session - Benzinga
- 3 months ago - Aditxt signs agreement to acquire Appili Therapeutics - Seeking Alpha
- 3 months ago - Aditxt Signs a Definitive Agreement to Acquire Appili Therapeutics Inc., Developer of a Biodefense Vaccine Funded by the U.S. Department of Defense (DoD) - Business Wire
- 3 months ago - Appili Therapeutics Signs Definitive Agreement to be Acquired by Aditxt, Inc. - GlobeNewsWire